Quarterly report pursuant to Section 13 or 15(d)

Schedule of Segment Information (Details)

v3.22.2.2
Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Segment Reporting Information [Line Items]          
Consolidated net revenue $ 24,200 $ 9,472 $ 100,824 $ 33,885  
Consolidated cost of revenue 12,227 5,495 41,453 16,515  
Total Depreciation and amortization expense 1,019 401 3,392 1,144  
Operating and other expenses 9,176 13,020 27,882 20,542  
Total income from operations, before income taxes 1,777 (3,978) 28,097 (4,316)  
Income tax expense (809) (7,190)  
Total income (loss) from operations, after income taxes 968 (3,978) 20,907 (4,316)  
Net income (loss) 968 (3,978) 20,907 (4,316)  
Total assets 97,877   97,877   $ 89,295
Diagnostic Services [Member]          
Segment Reporting Information [Line Items]          
Consolidated net revenue 20,541 7,142 91,613 27,416  
Consolidated cost of revenue 8,452 4,009 33,558 11,833  
Total Depreciation and amortization expense 584 401 1,755 1,138  
Total income from operations, before income taxes 6,776 (1,145) 39,671 2,859  
Total assets 53,631   53,631   51,150
Consumer Products [Member]          
Segment Reporting Information [Line Items]          
Consolidated net revenue 3,659 2,330 9,211 6,469  
Consolidated cost of revenue 3,775 1,486 7,895 4,682  
Total Depreciation and amortization expense 435 1,637 6  
Total income from operations, before income taxes (3,214) (958) (5,390) (453)  
Total assets 22,373   22,373   24,139
Unallocated Corporate [Member]          
Segment Reporting Information [Line Items]          
Total income from operations, before income taxes (1,785) $ (1,875) (6,184) $ (6,722)  
Total assets $ 21,873   $ 21,873   $ 14,006